Open Access

Gender-related plasma levels of progesterone, interleukin-8 and interleukin-10 during and after cardiopulmonary bypass in infants and children

  • Andreas Trotter1,
  • Kristina Mück1,
  • Hans-Jörg Grill2,
  • Uwe Schirmer3,
  • Andreas Hannekum4 and
  • Dieter Lang1
Critical Care20015:343

DOI: 10.1186/cc1067

Received: 26 March 2001

Accepted: 8 September 2001

Published: 1 October 2001

Abstract

Background

It is known that proinflammatory and anti-inflammatory cytokines are released during and after cardiopulmonary bypass (CPB) in infants and children. Sex steroids are known to have immunomodulatory functions, and release of the anti-inflammatory cytokine IL-10 is stimulated by progesterone in vitro. The purpose of the present study was to investigate the plasma levels of progesterone, IL-8 (proinflammatory cytokine) and IL-10, and to relate them to sex and postoperative morbidity.

Method

Eighteen infants and children (eight female) undergoing CPB were prospectively studied. Plasma levels of progesterone, IL-8 and IL-10 were determined before and 10 min after the start of CPB, and immediately after CPB; and 6 h, 24 h, 3 days and 7 days postoperatively. Organ dysfunction was identified on the basis of arbitrarily defined criteria.

Results

After CPB, all patients showed significant increases in plasma levels of progesterone, IL-8 and IL-10. Plasma levels of IL-10 were significantly higher in female patients, except for during the immediate postoperative period. According to the criteria used, six out of 10 male patients, but none of the female patients developed multiple organ dysfunction (MOD).

Conclusion

The present study shows that CPB induces a significant and marked increase in plasma levels of progesterone in infants and children. Studies of administration of progesterone-blocking substances to male and female animals may help to elucidate the roles of sex and progesterone in the setting of CBP.

Keywords

bypass children gender infants interleukin progesterone

Introduction

It is known that IL-8 (a proinflammatory cytokine) is released during and after CPB in adults [1], and in infants and children [2]. It has recently been shown [2,3] that IL-10 is released during and after CPB in infants and children. IL-10 serves as an anti-inflammatory agent and acts via suppressed macrophage production of proinflammatory mediators [4]. Sex steroids are known to have immunomodulatory functions. In vitro data [5] has shown that the production of proinflam-matory cytokines by fibroblasts can be suppressed by progesterone. The release of T-helper-2-type cytokines, which are predominantly anti-inflammatory cytokines, appears to be stimulated by progesterone [6,7,8]. In a pilot study conducted in 11 adults (three female) undergoing CPB for coronary–aortic bypass grafting [9], plasma levels of progesterone before and after the bypass were measured. Mean progesterone levels rose significantly from 0.13 to 0.90 ng/ml.

The purpose of the present study was to investigate the plasma levels of progesterone, IL-8 and IL-10 during and after CPB in infants and children, in relation to sex and postoperative morbidity.

Patients and method

Patients

The study was conducted at the University of Ulm. Infants and children were consecutively enrolled and underwent CPB if informed consent had been given by the parents. A total of 18 were included (median age 19 months, range 2 months to 15 years). On the day before the CPB, all patients had negative plasma levels of C-reactive protein and were not believed to have infections. Before the elective operation, the patients were in a haemodynamically stable condition and none of them had signs of heart failure. Diagnosis, type of operation, sex and age at operation of every patient are summarized in Table 1. None of the patients was pretreated with β-blockers. Patient 3 (pulmonary atresia with intact ventricular septum) was on prostaglandin and furosemide treatment, and patient 8 (ventricular septal defect) received digoxin. Patients 3 and 15 were cyanotic, with preoperative arterial oxygen saturations of 80 and 72%, respectively. Age, body weight and length, and body surface area were not significantly different between male and female patients (Table 2). The present study was approved by the Institutional Review Board of the University of Ulm.
Table 1

Diagnosis, type of operation, sex and age at operation of the 18 infants and children studied

Patient number (sex)

Diagnosis

Type of operation

Age (months)

1 (female)

ASD II

Closure

55

2 (female)

ASD II, AP window

Closure, transaortic patch

8

3 (male)

PA + IVS, PDA, AS

Valvulotomy of PV and AV, closure of PDA, AP shunt

2

4 (female)

VSD, PAB

Closure, debanding

42

5 (male)

VSD

Closure

19

6 (male)

SAS

Resection

182

7 (female)

VSD

Closure

30

8 (female)

VSD

Closure

24

9 (male)

Fallot, ASD II

Correction*

16

10 (male)

VSD, SAS, pulmonary hypertension

Closure, resection

15

11 (male)

VSD, PAB, corrected CoA

Closure, debanding

16

12 (female)

Fallot, FO

Correction

30

13 (female)

ASD II, CCAVB

Closure

24

14 (male)

Fallot, BTA

Correction, BTA closure

18

15 (male)

Fallot

Correction

10

16 (male)

Fallot (VACTERL)

Correction

20

17 (female)

Fallot

Correction

17

18 (male)

SAS

Resection

185

*Second cardiopulmonary bypass run because of a residual shunt. Resternotomy because of bleeding. AP = aortopulmonary; AS = aortic valve stenosis; ASD II, secundum atrioventricular defect; AV = aortic valve; BTA = Blalock-Taussig anastomosis; CCAVB = congenital complete atrioventricular block; CoA = coarctation of the aorta; Fallot = tetralogy of Fallot; FO = foramen ovale; IVS = intact ventricular septum; PA = pulmonary atresia; PAB = pulmonary artery banding; PDA = persistent ductus arteriosus; PV = pulmonary valve; SAS = subaortic stenosis; VACTERL = association of vertebral, anal, cardiac, tracheoesophageal, renal and limb defects; VSD = ventricular septal defect.

Table 2

Physical characteristics of the patients, and operative and outcome measures

Parameter

Male (n = 10)

Female (n = 8)

P

Age (months)

17 (2–185)

27 (8–55)

0.21

Body weight (kg)

9.6 (4.0–68)

10.4 (5.7–16)

0.72

Body length (cm)

80 (54–169)

81 (65–102)

0.76

Body surface area (m2)

0.45 (0.23–1.78)

0.46 (0.30–0.68)

0.72

Cardiopulmonary bypass time (min)

103 (79–218)*

89 (27–131)

0.08

Cross-clamping (min)

71 (31–129)*

46 (13–93)

0.10

Mechanical ventilation (h)

17 (2–111)

4.8 (2–18)

0.20

Intensive care unit (days)

2 (1–20)

2 (1–5)

0.51

Multiple organ dysfunction (n)

6

0

0.01

Median (minimum, maximum) age, body weight and length, body surface area at operation and duration of cardiopulmonary bypass, aortic cross-clamping time, duration of mechanical ventilation, and days on the intensive care unit for male and female patients (Mann–Whitney U-test). The incidence of multiple organ dysfunction is also shown (Fisher's exact test). *Times for the patient who underwent a second cardiopulmonary bypass run because of a residual shunt are cumulative.

Procedure

Anaesthesia was induced and maintained with fentanyl, midazolam (except in patients 6 and 18, who received clorazepate) and vecuronium bromide. Further anaesthetics were used in five male patients (enflurane in patients 9–11 and propofol in patients 6 and 18) and in three female patients (enflurane in patients 1, 8 and 13, and propofol in patient 1). A tri-lumen central venous line was inserted into the internal jugular vein. For the monitoring of arterial blood pressure, an arterial line was placed into the radial artery. Volume-controlled ventilation was applied (SERVO 900 C respirator; Siemens, Munich, Germany). A transurethral catheter was inserted in all patients in order to monitor fluid balance.

The CPB was performed using a CAPS-roller pump system (Stöckert Instruments, Munich, Germany) with continuous flow. The system was connected to a membrane oxygenator (Dideco, Sorin Biomedica, Puchheim, Germany; Cobe Optima, Cobe Laboratories, Planegg-Martinsried, Germany) and an arterial filter. The priming solution consisted of ringer solution and sodium bicarbonate, and contained 2 IU/ml heparin-sodium and 1.5% human albumin. If the haematocrit was expected to drop to below 25% after the patient was connected to the bypass circuit, then red packed cells were added (which contained no detectable levels of progesterone).

After the sternotomy had been conducted (patients 1 and 13 had a right-sided thoracotomy for atrial septal defect type II closure), 30,000 IU/kg aprotinin were administered over a period of 20 min and the administration was continued with 7500 IU/kg per h throughout the operation. Before cannulation of the patient's heart, 300 IU heparin-sodium/kg was given intravenously in order to achieve an activated clotting time of greater than 400s. No corticosteroids were given before or during the operation. After the caval veins, the left atrium and the aorta had been cannulated, hypothermia was induced by cooling down the priming solution (median oesophageal temperature 28.5°C; minimum 28°C and maximum 33°C). A secundum type atrial septal defect in patients 1 and 13 was closed under normothermic conditions. After electrical fibrillation of the heart, 30 ml/kg cold Bretschneider solution was infused into the cross-clamped aortic bulbus. The perfusion index was adjusted to 2.5 ml/kg per m2 with the CPB system. At the end of the procedure rewarming was started. Catecholamines were used whenever systemic perfusion was impaired. Heparinization was countered using 300 IU/kg protamine-hydrochloride. The ventilated patients were transferred to the cardiac intensive care unit.

The patients were weaned from the respirator as soon as possible. Crystalloid fluid management consisted of 40 ml/kg per day during the first postoperative day, increasing by approximately 10 ml/kg every other day. Fresh frozen plasma or thrombocytes were given if the patient had postoperative bleeding (>3 ml/kg perh), or if the prothrombin time was below 40% of normal or the thrombocyte count was below 50,000/μl, respectively. Furosemide (0.5–1 mg/kg per dose) was used to facilitate diuresis. Blood pressure was maintained within age-specific ranges with catecholamines (dopamine, dobutamine, adrenaline, noradrenaline).

Laboratory data

Blood samples were taken immediately before the operation; after induction of anaesthesia and administration of heparin; 10 min after the commencement of CPB; after disconnection from the circuit and administration of protamine; and 6 h, 24 h, 3 days and 7 days postoperatively. Additional blood samples were taken when this was clinically indicated.

Blood cell counts, electrolytes, urea nitrogen, creatinine, protein, creatine kinase, heart-specific creatine kinase, aspartate aminotransferase, bilirubin, prothrombin time, partial thromboplastin time, fibrinogen and antithrombin III were measured using standard methods. Plasma levels of progesterone were measured in EDTA-medium using a RIA-kit (Coat-A-Count Progesterone; Diagnostic Products Corporation, Los Angeles, CA, USA). The detection limit was 0.02 ng/ml. The intra- and inter-assay coefficient of variation was 4.0 and 5.3% at 1.5 ng/ml, respectively. The test has no detectable cross-reactivity with aldosterone. IL-8 plasma levels were determined immediately after the blood was drawn (EDTA-coated tubes) using a chemiluminescence immunoassay (Immulite; DPC-Biermann, Bad Nauheim, Germany). The lower detection limit for this assay was 5 pg/ml. The assay was calibrated up to 10,000 pg/ml. Intra- and inter-assay coefficient of variation was below 5% and below 2% at 95 pg/ml, respectively. All IL-10 plasma samples (EDTA-coated tubes) were frozen at -70°C and then measured using an enzyme-linked immunoassay (LD Zytokit IL-10 ELISA; LD Labordiagnostica, Heiden, Germany). The assay had a lower limit of detection of 15 pg/ml. Intra- and inter-assay coefficient of variation was 4.0 and 5.5% at 130 pg/ml, respectively. The IL-10 levels at 6 h postoperatively could not be measured because immediate workup of the samples was not possible.

Clinical criteria for multiple organ dysfunction

The different organ systems considered and the criteria used to define the dysfunction of an organ system are summarized in Table 3. MOD was diagnosed if two or more organ systems were affected. The occurrence of organ dysfunction was monitored for as long as the patient was in the intensive care unit.
Table 3

Definition of organ dysfunction

Dysfunctional organ system

Criteria

Renal

Urine output ≤ 1 ml/kg per h or serum creatinine ≥ 100 μmol/l

Respiratory

Ventilatory support with inspired oxygen fraction ≥ 0.4 for more than 5 days postoperatively

Hepatic

Aspartate aminotransferase ≥ 500 IU/L or prothrombin time* ≤ 50%

Cardiac

Need for catecholamines >24 h postoperatively

Haematological

Thrombocytes <100,000/μl

Neurological

Seizures or coma

*Patient/control value. Dopamine <5 μg/kg per min excluded.

Statistical analysis

The nonparametric Mann–Whitney U-test and the Wilcoxon test were used to analyze the results. Medians with interquartile ranges were used in the graphs. Correlations were calculated using Spearman's method. Differences in outcome were analyzed using the Fisher's Exact Test for categorical variables. P < 0.05 was considered statistically significant. Because of the small sample size, no multivariate regression analysis was performed. This was an explorative study without confirmatory design, and therefore no correction for repeated comparisons was performed.

Results

After CPB, all patients showed a significant increase in plasma levels of progesterone, IL-8 and IL-10 (Wilcoxon test). Plasma levels of progesterone and IL-8 showed no differences between male and female patients (Fig. 1; Mann–Whitney U-test). Plasma levels of IL-10 were significantly greater in female patients, except for during the immediate postoperative period (Fig. 1). Progesterone plasma levels were not correlated to patient age. No correlation between progesterone and IL-10 plasma levels in female patients was found at any sample time. After disconnection from the bypass circuit, plasma levels of IL-8 and IL-10, but not that of progesterone, were significantly correlated to the duration of the CPB (r = 0.54 and 0.60, P < 0.05 and P < 0.01 Spearman's method, respectively).
https://static-content.springer.com/image/art%3A10.1186%2Fcc1067/MediaObjects/13054_2001_Article_1108_Fig1_HTML.jpg
Figure 1

Plasma levels of progesterone (upper panel), IL-8 (middle panel) and IL-10 (lower panel; semi-logarithmic Y-scale) at different sample times for female (n = 8, open bars) and male (n = 10, hatched bars) patients (*P < 0.05, medians with interquartile ranges). The horizontal bar represents the period of cardiopulmonary bypass (CPB).

CPB time, aortic cross-clamping time, duration of mechanical ventilation and days on the intensive care unit for the male and female patients are summarized in Table 2. There were no significant differences between the two groups. According to the defined criteria for organ dysfunction, six out of 10 male patients but none of the female patients developed MOD (P = 0.01). The haematological system was most frequently affected (83%, n = 15), followed by the cardiac and renal systems (22% each), and hepatic and neurological systems (6% each). None of the patients needed ventilatory support for more than 5 days postoperatively, and all patients survived.

Discussion

Normative data for the prepubertal age show no sex-specific differences in plasma levels of progesterone [10], and this was found for the preoperative values in the predominantly prepubertal patients included in the present study. During CPB plasma progesterone levels increased in all patients, with no correlation to patient age or sex. It is unlikely that the progesterone increase is of gonadal origin. We did not determine the level of gonadotrophic hormones during and after bypass. No changes in the secretion rate of luteinizing hormone were found during and after CPB in adults [11]. An increase in aldosterone level after open heart surgery has been described in children [12] and adults [13]. For adult patients, it has been suggested that activation of the renin-angiotensin-aldosterone axis may be responsible for the observed changes in plasma aldosterone [13]. Progesterone is a precursor of aldosterone synthesis in the adrenal cortex. Whether the increase in plasma levels of progesterone during and after CPB is caused by an activated renin-angiotensin-aldosterone axis or whether the increase is the result of a CPB-related diminished metabolic rate for progesterone remains unknown.

It has been suggested that IL-10 may play a protective role by downregulating the production of proinflammatory cytokines after CPB [2]. We identified an increase in IL-10 levels, peaking after the disconnection from the bypass circuit, which is in accordance with recently published data [3]. In vitro data [14,15] showed that, after administration of exogeneous progesterone, β2-adrenoreceptors on lymphocytes are upregulated in females, but not in males. The β2-adrenoreceptor is known to mediate anti-inflammatory effects (e.g. the release of IL-10 [16]). On the basis of these in vitro data, it can be speculated that even identical amounts of progesterone may result in different anti-inflammatory effects in females as compared with males. No correlation was found between plasma levels of progesterone and IL-10 in the female patients included in the present study. In recent studies addressing human sepsis [17,18], women had a significantly better prognosis than did men, and this was related to increased levels of IL-10 in the women. In contrast to those findings, female sex was identified as a risk factor for mortality after cardiac surgery with CPB [19].

Evaluation of the clinical course following cardiac surgery was conducted by defining organ dysfunction. There is some controversy in the literature that is relevant to the definition of organ dysfunction in infants and children. If we apply the MOD criteria defined by Wilkinson et al. [20] to the present data, the incidence of MOD would have been 50% (n = 9). Wilkinson et al. found an incidence of MOD of 27% in 831 paediatric intensive care unit patients, but they did not distinguish between postoperative cardiac surgery patients and others. Seghaye et al. [21] used a different definition of MOD for patients following cardiac surgery. If we apply those criteria to our patients, the incidence of MOD would have been only 6% (n = 1). We arbitrarily defined the criteria for organ dysfunction that fitted best the postoperative morbidity of our patients. All patients included in the present study who developed MOD were male. This would suggest that sex is the main factor in determining postoperative morbidity in infants and children. However, our arbitrary definition of organ dysfunction has limitations. Thrombocytopenia was the most common finding, the sample size was small, and the patients had various diagnoses and types of operation.

To our knowledge, this is the first study in which progesterone and the changes that occur in its plasma levels during and after CPB have been followed. After CPB a significant and marked increase in plasma levels of progesterone was identified. We were also able to confirm the known CPB-induced release of IL-8 and IL-10. Female patients had significantly higher plasma levels of IL-10 even preoperatively, and none of them developed MOD. Sex-related differences in postoperative morbidity cannot be supported by these preliminary data. Limitations include the small and very inhomogeneous group of patients with regard to age and diagnosis, and the arbitrary definition of MOD. Studies of administration of progesterone-blocking substances in male and female animals may help to elucidate the role of sex and progesterone in the setting of CBP.

Abbreviations

CPB: 

CPB = cardiopulmonary bypass

IL: 

IL = interleukin

MOD: 

MOD = multiple organ dysfunction.

Declarations

Authors’ Affiliations

(1)
Section of Pediatric Cardiology, Children's Hospital, University of Ulm
(2)
Department of Obstetrics and Gynecology, University of Ulm
(3)
Department of Cardiac Anesthesia, University of Ulm
(4)
Department of Cardiac Surgery, University of Ulm

References

  1. Jorens P, De Jongh R, De Backer W, Van Damme J, Van Overveld F, Bossaert L, Walter P, Herman A, Rampart M: Interleukin-8 production in patients undergoing cardiopulmonary bypass. The influence of pretreatment with methylprednisolone. Am Rev Respir Dis 1993, 148: 890-895.View ArticlePubMedGoogle Scholar
  2. Seghaye M, Duchateau J, Bruniaux J, Demontoux S, Bosson C, Serraf A, Lecronier G, Mokhfi E, Planche C: Interleukin-10 release related to cardiopulmonary bypass in infants undergoing cardiac operations. J Thorac Cardiovasc Surg 1996, 111: 545-553.View ArticlePubMedGoogle Scholar
  3. Tárnok A, Hambsch J, Schneider P: Cardiopulmonary bypass-induced increase of serum interleukin-10 levels in children. J Thorac Cardiovasc Surg 1998, 115: 475-477.View ArticlePubMedGoogle Scholar
  4. Rennick D, Berg D, Holland G: Interleukin 10: an overview. Prog Growth Factor Res 1992, 4: 207-227.View ArticlePubMedGoogle Scholar
  5. Lapp CA, Thomas ME, Lewis JB: Modulation by progesterone of interleukin-6 production by gingival fibroblasts. J Peridontol 1995, 66: 279-284.View ArticleGoogle Scholar
  6. Wegmann T, Lin H, Guilbert L, Mosmann T: Bidirectional cytokine interactions in the maternal-fetal relationship: is successful pregnancy a TH2 phenomenon? Immunol Today 1993, 14: 353-356. 10.1016/0167-5699(93)90235-DView ArticlePubMedGoogle Scholar
  7. Szekeres-Bartho J, Autran B, Debre P, Andreu G, Denver L, Chaouat G: Immunoregulatory effects of a suppressor factor from healthy pregnant women's lymphocytes after progesterone induction. Cell Immunol 1989, 122: 281-294.View ArticlePubMedGoogle Scholar
  8. Piccinni M, Romagnani S: Regulation of fetal allograft survival by a hormone-controlled Th1- and Th2-type cytokines. Immunol Res 1996, 15: 141-150.View ArticlePubMedGoogle Scholar
  9. Trotter A, Grill H, Hemmer W, Hannekum A, Lang D: Sex steroids in cardiopulmonary bypass. Crit Care 1997, 1: 85-87. 10.1186/cc109PubMed CentralView ArticlePubMedGoogle Scholar
  10. Sippell W, Dorr H, Bidlingmaier F, Knorr D: Plasma levels of aldosterone, corticosterone, 11-deoxycorticosterone, progesterone, 17-hydroxyprogesterone, cortisol, and cortisone during infancy and childhood. Pediatr Res 1980, 14: 39-46.View ArticlePubMedGoogle Scholar
  11. Yokota H, Kawashima Y, Hashimoto S, Manabe H, Onishi T, Aono T, Matsumoto K: Plasma cortisol, luteinizing hormone (LH), and prolactin secretory responses to cardiopulmonary bypass. J Surg Res 1977, 23: 196-200.View ArticlePubMedGoogle Scholar
  12. Burch M, Lum L, Elliott M, Carter N, Slater D, Smith A, Ationu A: Influence of cardiopulmonary bypass on water balance hormones in children. Br Heart J 1992, 68: 309-312.PubMed CentralView ArticlePubMedGoogle Scholar
  13. Barta E, Kuzela L, Tordova E, Horecky J, Babusikova F: The blood volume and the renin-angiotensin-aldosterone system following open-heart surgery. Resuscitation 1980, 8: 137-146.View ArticlePubMedGoogle Scholar
  14. Tan KS, McFarlane LC, Coutie WJ, Lipworth BJ: Effects of exogenous female sex-steroid hormones on lymphocyte beta 2-adrenoceptors in normal females. Br J Clin Pharmacol 1996, 41: 414-416. 10.1046/j.1365-2125.1996.3311.xPubMed CentralView ArticlePubMedGoogle Scholar
  15. Tan KS, McFarlane LC, Lipworth BJ: Effect of exogenous female sex-steroid hormones on beta 2-adrenoceptors in healthy males. Eur J Clin Pharmacol 1997, 52: 281-283. 10.1007/s002280050290View ArticlePubMedGoogle Scholar
  16. Tighe D, Moss R, Bennett D: Cell surface adrenergic receptor stimulation modifies the endothelial response to SIRS. Systemic Inflammatory Response Syndrome. New Horiz 1996, 4: 426-442.PubMedGoogle Scholar
  17. Schröder J, Kahlke V, Staubach KH, Zabel P, Stuber F: Gender differences in human sepsis. Arch Surg 1998, 133: 1200-1205. 10.1001/archsurg.133.11.1200View ArticlePubMedGoogle Scholar
  18. Wichmann MW, Inthorn D, Andress HJ, Schildberg FW: Incidence and mortality of severe sepsis in surgical intensive care patients: the influence of patient gender on disease process and outcome. Intensive Care Med 2000, 26: 167-172. 10.1007/s001340050041View ArticlePubMedGoogle Scholar
  19. Roques F, Nashef SA, Michel P, Gauducheau E, de Vincentiis C, Baudet E, Cortina J, David M, Faichney A, Gabrielle F, Gams E, Harjula A, Jones MT, Pintor PP, Salamon R, Thulin L: Risk factors and outcome in European cardiac surgery: analysis of the EuroSCORE multinational database of 19030 patients. Eur J Cardiothorac Surg 1999, 15: 816-822. 10.1016/S1010-7940(99)00106-2View ArticlePubMedGoogle Scholar
  20. Wilkinson JD, Pollack MM, Ruttimann UE, Glass NL, Yeh TS: Outcome of pediatric patients with multiple organ system failure. Crit Care Med 1986, 14: 271-274.View ArticlePubMedGoogle Scholar
  21. Seghaye MC, Duchateau J, Grabitz RG, Faymonville ML, Messmer BJ, Buro-Rathsmann K, von Bernuth G: Complement activation during cardiopulmonary bypass in infants and children. Relation to postoperative multiple system organ failure. J Thorac Cardiovasc Surg 1993, 106: 978-987.PubMedGoogle Scholar

Copyright

© Trotter et al., licensee BioMed Central Ltd 2001

Advertisement